Israel Englander Bio Xcel Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 104,972 shares of BTAI stock, worth $230,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,972

Previous 128,773 18.48%

Holding current value

$230,938

Previous $78,000 51.28%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.32 - $0.73 $7,616 - $17,374	-23,801 Reduced 18.48%	104,972 $38,000
Q3 2024 Nov 14, 2024	BUY	$0.53 - $1.34 $3,191 - $8,068	6,021 Added 4.91%	128,773 $78,000
Q2 2024 Aug 14, 2024	BUY	$1.14 - $2.97 $88,495 - $230,555	77,628 Added 172.03%	122,752 $157,000
Q1 2024 May 15, 2024	SELL	$1.95 - $4.04 $83,512 - $173,021	-42,827 Reduced 48.69%	45,124 $127,000
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $204,046 - $484,610	87,951 New	87,951 $259,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $1.53 Million - $3.65 Million	169,163 Added 872.65%	188,548 $2.49 Million
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $2,025 - $3,082	135 Added 0.7%	19,385 $405,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $387,310 - $675,482	19,250 New	19,250 $391,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $424,188 - $566,801	-14,597 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $1.82 Million - $3.01 Million	-46,548 Reduced 76.13%	14,597 $630,000
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $933,058 - $1.24 Million	-21,975 Reduced 26.44%	61,145 $2.83 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $1.87 Million - $3.23 Million	49,959 Added 150.66%	83,120 $3.6 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $584,296 - $1.95 Million	33,161 New	33,161 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	$8.99 - $11.79 $115,692 - $151,725	-12,869 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.49 - $10.47 $44,912 - $134,738	12,869 New	12,869 $127,000
Q3 2018 Nov 14, 2018	SELL	$7.51 - $12.99 $343,927 - $594,890	-45,796 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.02 - $11.26 $104,647 - $167,852	14,907 Added 48.26%	45,796 $421,000
Q1 2018 May 15, 2018	BUY	$9.83 - $11.03 $303,638 - $340,705	30,889 New	30,889 $316,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

8.63M

Call Options Held

34.5K

Put Options Held

59.4K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $61.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account